Generating real-world evidence in early Alzheimer's disease: Considerations for applying the target trial emulation framework to study the safety of anti-amyloid therapies Article

publication date

  • April 1, 2025

webpage

published in

keywords

  • Alzheimer's disease
  • anti-amyloid beta monoclonal antibodies
  • real-world data
  • real-world evidence
  • target trial emulation

volume

  • 11

issue

  • 2